Risk factors associated with relapse in Japanese patients with microscopic polyangiitis

Takashi Wada1, Akinori Hara, Yoshihiro Arimura

  • 1Division of Nephrology, Department of Laboratory Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. twada@m-kanazawa.jp

The Journal of Rheumatology
|December 17, 2011
PubMed
Abstract

Insights

Relapse in myeloperoxidase-antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive microscopic polyangiitis (MPA) is linked to how quickly prednisolone is reduced during maintenance therapy. Careful monitoring of prednisolone reduction rates is crucial for preventing MPO-ANCA-positive MPA relapses.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) is a serious autoimmune condition.
  • Myeloperoxidase-antineutrophil cytoplasmic autoantibody (MPO-ANCA) positivity is a key diagnostic marker for MPA.
  • Maintaining remission in MPA is critical to prevent disease flares and organ damage.

Purpose of the Study:

  • To identify risk factors for relapse during maintenance therapy in MPO-ANCA-positive MPA patients.
  • To investigate the association between prednisolone reduction rates and relapse risk.
  • To understand predictors of vasculitis damage index in MPA.

Main Methods:

  • Retrospective study of 62 MPA patients achieving remission.
  • Analysis of patient data from January 2005 to December 2006.
  • Statistical analysis to identify risk factors for relapse and vasculitis damage index.

Main Results:

  • Relapse rate was 24.2% (15/62) with a mean remission-relapse interval of 16.9 months.
  • Increased risk of relapse observed when prednisolone reduction rate exceeded 0.8 mg/month (OR 12.6).
  • Proteinuria and changes in urinary red blood cell counts were risk factors for vasculitis damage index.

Conclusions:

  • The rate of prednisolone reduction during maintenance therapy is a significant factor associated with relapse in MPO-ANCA-positive MPA in Japan.
  • Close monitoring of prednisolone tapering is essential for managing MPO-ANCA-positive MPA.
  • Proteinuria and hematuria changes may indicate increased disease activity or damage.

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...